HigA2 (Rv2021c) Is a Transcriptional Regulator with Multiple Regulatory Targets in Mycobacterium tuberculosis
M Xu, M Liu, T Liu, X Pan, Q Ren, T Han, L Gou - Microorganisms, 2024 - mdpi.com
Toxin-antitoxin (TA) systems are the major mechanism for persister formation in
Mycobacterium tuberculosis (Mtb). Previous studies found that HigBA2 (Rv2022c-Rv2021c) …
Mycobacterium tuberculosis (Mtb). Previous studies found that HigBA2 (Rv2022c-Rv2021c) …
Screening of Microbial Fermentation Products for Anti-M. tuberculosis Activity
A Reheman, D Lu, Y Wang, X Chen, G Cao, C Wan - Animals, 2022 - mdpi.com
Simple Summary M. tuberculosis (M. tb) is the main pathogen of tuberculosis (TB). The
emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) M. tb has …
emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) M. tb has …
Antibiotics in the management of tuberculosis and cancer
Drugs that were formerly thought to be life-saving miracles are now rendered useless due to
pathogen's defense mechanisms. It is more difficult to fight or cure the infectious disease and …
pathogen's defense mechanisms. It is more difficult to fight or cure the infectious disease and …
[PDF][PDF] ROL DE LAS METALOCHAPERONAS CANDIDATAS EN EL MECANISMO DE ACCIÓN Y RESISTENCIA A PIRAZINAMIDA EN MYCOBACTERIUM …
FDM CARPIO - repositorio.upch.edu.pe
La tuberculosis (TB) es una enfermedad infecciosa ocasionada por la bacteria
Mycobacterium tuberculosis. Esta enfermedad es considerada como un problema dentro de …
Mycobacterium tuberculosis. Esta enfermedad es considerada como un problema dentro de …
Complejos metálicos con potencial aplicación para el tratamiento de la tuberculosis
CK Guillén Chucho - tesis.pucp.edu.pe
La tuberculosis (TB) es una enfermedad epidémica causada por la bacteria Mycobacterium
tuberculosis, que suele afectar principalmente a los sectores más vulnerables de la …
tuberculosis, que suele afectar principalmente a los sectores más vulnerables de la …
[PDF][PDF] Journal of Population Therapeutics & Clinical Pharmacology
A Verma, A Kashyap, R Saini, R Dogra, A Sharma… - Expert …, 1980 - researchgate.net
Abstract Advancements in Artificial Intelligence (AI) have transformed the landscape of
oncology, offering unprecedented opportunities for improved cancer research and clinical …
oncology, offering unprecedented opportunities for improved cancer research and clinical …